{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:12:37Z","timestamp":1788174757097,"version":"build-2803163510"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:00:00Z","timestamp":1642982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:00:00Z","timestamp":1642982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"DOI":"10.1007\/s12016-022-08923-3","type":"journal-article","created":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T14:02:49Z","timestamp":1643032969000},"page":"343-357","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Heart Involvement in Systemic Sclerosis: the Role of Magnetic Resonance Imaging"],"prefix":"10.1007","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5306-7714","authenticated-orcid":false,"given":"Giacomo","family":"De Luca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Bombace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Monti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,24]]},"reference":[{"issue":"10103","key":"8923_CR1","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","volume":"390","author":"CP Denton","year":"2017","unstructured":"Denton CP, Khanna D (2017) Systemic sclerosis. Lancet 390(10103):1685\u20131699. https:\/\/doi.org\/10.1016\/S0140-6736(17)30933-9 (Epub 2017 Apr 13 PMID: 28413064)","journal-title":"Lancet"},{"key":"8923_CR2","doi-asserted-by":"publisher","unstructured":"Champion HC (2008) The heart in scleroderma.\u00a0Rheum Dis Clin North Am 34(1):181-viii. https:\/\/doi.org\/10.1016\/j.rdc.2007.12.002","DOI":"10.1016\/j.rdc.2007.12.002"},{"key":"8923_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2021.101668","volume":"15","author":"C Bruni","year":"2021","unstructured":"Bruni C, Ross L (2021) Cardiac involvement in systemic sclerosis: getting to the heart of the matter. Best Pract Res Clin Rheumatol 15:101668. https:\/\/doi.org\/10.1016\/j.berh.2021.101668","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"8923_CR4","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1136\/ard.2009.114264","volume":"69","author":"JA Tyndall","year":"2010","unstructured":"Tyndall JA, Bannert B, Vonk M, Air\u00f2 P, Cozzi F, Carreira PE et al (2010) Causes and risk factors for death in systemic sclerosis: a study from the Systemic sclerosis myocarditis EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 69:1809\u20131815. https:\/\/doi.org\/10.1136\/ard.2009.114264","journal-title":"Ann Rheum Dis"},{"key":"8923_CR5","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1093\/rheumatology\/kew488","volume":"56","author":"LA Bissell","year":"2017","unstructured":"Bissell LA, Anderson M, Burgess M et al (2017) Consensus best practice pathway of the UK Systemic Sclerosis Study group: management of cardiac disease in systemic sclerosis. Rheumatology 56:912\u2013921","journal-title":"Rheumatology"},{"issue":"1","key":"8923_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.semarthrit.2017.03.020","volume":"47","author":"SI Mavrogeni","year":"2017","unstructured":"Mavrogeni SI, Schwitter J, Gargani L, Pepe A, Monti L, Allanore Y, Matucci-Cerinic M (2017) Cardiovascular magnetic resonance in systemic sclerosis: \u201cPearls and pitfalls.\u201d Semin Arthritis Rheum 47(1):79\u201385. https:\/\/doi.org\/10.1016\/j.semarthrit.2017.03.020 (Epub 2017 Mar 31 PMID: 28522072)","journal-title":"Semin Arthritis Rheum"},{"key":"8923_CR7","doi-asserted-by":"publisher","unstructured":"Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, White JA, Abdel-Aty H, Gutberlet M, Prasad S, Aletras A, Laissy JP, Paterson I, Filipchuk NG, Kumar A, Pauschinger M, Liu P (2009) International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis. Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J Am Coll Cardiol 53(17):1475\u201387.\u00a0https:\/\/doi.org\/10.1016\/j.jacc.2009.02.007.","DOI":"10.1016\/j.jacc.2009.02.007"},{"issue":"24","key":"8923_CR8","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1016\/j.jacc.2018.09.072","volume":"72","author":"VM Ferreira","year":"2018","unstructured":"Ferreira VM, Schulz-Menger J, Holmvang G, Kramer CM, Carbone I, Sechtem U, Kindermann I, Gutberlet M, Cooper LT, Liu P, Friedrich MG (2018) Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J Am Coll Cardiol 72(24):3158\u20133176. https:\/\/doi.org\/10.1016\/j.jacc.2018.09.072","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"8923_CR9","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1148\/radiol.2020191623","volume":"295","author":"A Palmisano","year":"2020","unstructured":"Palmisano A, Benedetti G, Faletti R, Rancoita PMV, Gatti M, Peretto G, Sala S, Boccia E, Francone M, Galea N, Basso C, Del Maschio A, De Cobelli F, Esposito A (2020) Early T1 myocardial MRI mapping: value in detecting myocardial hyperemia in acute myocarditis. Radiology 295(2):316\u2013325. https:\/\/doi.org\/10.1148\/radiol.2020191623","journal-title":"Radiology"},{"issue":"4","key":"8923_CR10","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.carpath.2011.10.001","volume":"21","author":"O Leone","year":"2012","unstructured":"Leone O, Veinot JP, Angelini A et al (2012) 2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology. Cardiovasc Pathol 21(4):245\u2013274. https:\/\/doi.org\/10.1016\/j.carpath.2011.10.001","journal-title":"Cardiovasc Pathol"},{"issue":"3","key":"8923_CR11","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1161\/01.cir.53.3.483","volume":"53","author":"BH Bulkley","year":"1976","unstructured":"Bulkley BH, Ridolfi RL, Salyer WR, Hutchins GM (1976) Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction Circulation 53(3):483\u2013490. https:\/\/doi.org\/10.1161\/01.cir.53.3.483","journal-title":"A cause of cardiac dysfunction Circulation"},{"issue":"5","key":"8923_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126707","volume":"10","author":"KA Mueller","year":"2015","unstructured":"Mueller KA, Mueller II, Eppler D, Zuern CS, Seizer P, Kramer U, Koetter I, Roecken M, Kandolf R, Gawaz M, Geisler T, Henes JC, Klingel K (2015) Clinical and histopathological features of patients with systemic sclerosis undergoing endomyocardial biopsy. PLoS ONE 10(5):e0126707. https:\/\/doi.org\/10.1371\/journal.pone.0126707","journal-title":"PLoS ONE"},{"issue":"9","key":"8923_CR13","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1093\/rheumatology\/kez658","volume":"59","author":"G De Luca","year":"2020","unstructured":"De Luca G, Campochiaro C, De Santis M, Sartorelli S, Peretto G, Sala S et al (2020) Systemic sclerosis myocarditis has unique clinical, histological and prognostic features: a comparative histological analysis. Rheumatology (Oxford) 59(9):2523\u20132533. https:\/\/doi.org\/10.1093\/rheumatology\/kez658","journal-title":"Rheumatology (Oxford)"},{"key":"8923_CR14","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1136\/ard.2008.095836","volume":"68","author":"AL Hachulla","year":"2009","unstructured":"Hachulla AL, Launay D, Gaxotte V, de Groote P, Lamblin N, Devos P et al (2009) Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients. Ann Rheum Dis 68:1878\u20131884","journal-title":"Ann Rheum Dis"},{"key":"8923_CR15","doi-asserted-by":"publisher","first-page":"3827","DOI":"10.1002\/art.22971","volume":"56","author":"GE Tzelepis","year":"2007","unstructured":"Tzelepis GE, Kelekis NL, Plastiras SC, Mitseas P, Economopoulos N, Kampolis C et al (2007) Pattern and distribution of myocardial fibrosis in systemic scleroderma, a delayed enhanced MRI study. Arthritis Rheum 56:3827\u20133836","journal-title":"Arthritis Rheum"},{"issue":"4","key":"8923_CR16","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/rheumatology\/keu350","volume":"54","author":"TS Rodr\u00edguez-Reyna","year":"2015","unstructured":"Rodr\u00edguez-Reyna TS, Morelos-Guzman M, Hern\u00e1ndez-Reyes P, Montero-Duarte K, Mart\u00ednez-Reyes C, Reyes-Utrera C, Vazquez-La Madrid J, Morales-Blanhir J, N\u00fa\u00f1ez-\u00c1lvarez C, Cabiedes-Contreras J (2015) Assessment of myocardial fibrosis and microvascular damage in systemic sclerosis by magnetic resonance imaging and coronary angiotomography. Rheumatology (Oxford) 54(4):647\u2013654. https:\/\/doi.org\/10.1093\/rheumatology\/keu350","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"8923_CR17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3899\/jrheum.080377","volume":"36","author":"H Kobayashi","year":"2009","unstructured":"Kobayashi H, Yokoe I, Hirano M, Nakamura T, Nakajima Y, Fontaine KR, Giles JT, Kobayashi Y (2009) Cardiac magnetic resonance imaging with pharmacological stress perfusion and delayed enhancement in asymptomatic patients with systemic sclerosis. J Rheumatol 36(1):106\u2013112. https:\/\/doi.org\/10.3899\/jrheum.080377","journal-title":"J Rheumatol"},{"key":"8923_CR18","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.semarthrit.2013.07.006","volume":"43","author":"M Pieroni","year":"2014","unstructured":"Pieroni M, De Santis M, Zizzo G, Bosello S, Smaldone C, Campioni M et al (2014) Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression. Semin Arthritis Rheum 43:526\u2013535. https:\/\/doi.org\/10.1016\/j.semarthrit.2013.07.006","journal-title":"Semin Arthritis Rheum"},{"key":"8923_CR19","first-page":"308","volume":"86","author":"J Moon","year":"2001","unstructured":"Moon J, Coghlan JG, Pennell DJ (2001) Systemic sclerosis involving the heart. Heart 86:308","journal-title":"Heart"},{"key":"8923_CR20","doi-asserted-by":"crossref","unstructured":"Plastiras SC, Kele kis N, Tzelepis GE (2006) Magnetic resonance imaging for the detection of myocardial fibrosis in scleroderma. N Engl J Med 354:2194\u20136","DOI":"10.1056\/NEJMc053128"},{"issue":"252","key":"8923_CR21","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.ijcard.2017.11.032","volume":"1","author":"S Mavrogeni","year":"2018","unstructured":"Mavrogeni S, Schwitter J, van Rossum A, Nijveldt R, Aletras A, Kolovou G, Pohost G, Lima J (2018) Cardiac magnetic resonance imaging in myocardial inflammation in autoimmune rheumatic diseases: an appraisal of the diagnostic strengths and limitations of the Lake Louise criteria. Int J Cardiol 1(252):216\u2013219. https:\/\/doi.org\/10.1016\/j.ijcard.2017.11.032","journal-title":"Int J Cardiol"},{"issue":"8","key":"8923_CR22","doi-asserted-by":"publisher","first-page":"658","DOI":"10.4070\/kcj.2020.0157.PMID:32725975;PMCID:PMC7390720","volume":"50","author":"VM Ferreira","year":"2020","unstructured":"Ferreira VM, Piechnik SK (2020) CMR parametric mapping as a tool for myocardial tissue characterization. Korean Circ J 50(8):658\u2013676. https:\/\/doi.org\/10.4070\/kcj.2020.0157.PMID:32725975;PMCID:PMC7390720","journal-title":"Korean Circ J"},{"issue":"1","key":"8923_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1532-429X-16-21","volume":"16","author":"NA Ntusi","year":"2014","unstructured":"Ntusi NA, Piechnik SK, Francis JM, Ferreira VM, Rai AB, Matthews PM, Robson MD, Moon J, Wordsworth PB, Neubauer S, Karamitsos TD (2014) Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis\u2013a clinical study using myocardial T1-mapping and extracellular volume quantification. J Cardiovasc Magn Reson 16(1):21. https:\/\/doi.org\/10.1186\/1532-429X-16-21","journal-title":"J Cardiovasc Magn Reson"},{"issue":"12","key":"8923_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0244282","volume":"15","author":"N Galea","year":"2020","unstructured":"Galea N, Rosato E, Gigante A, Borrazzo C, Fiorelli A, Barchetti G, Trombetta AC, Digiulio MA, Francone M, Catalano C, Carbone I (2020) Early myocardial damage and microvascular dysfunction in asymptomatic patients with systemic sclerosis: a cardiovascular magnetic resonance study with cold pressor test. PLoS ONE 15(12):e0244282. https:\/\/doi.org\/10.1371\/journal.pone.0244282","journal-title":"PLoS ONE"},{"issue":"2","key":"8923_CR25","doi-asserted-by":"publisher","first-page":"162.e1","DOI":"10.1016\/j.crad.2020.09.023","volume":"76","author":"V Bordonaro","year":"2021","unstructured":"Bordonaro V, Bivort D, Dresselaers T, De Langhe E, Bogaert J, Symons R (2021) Myocardial T1 mapping and extracellular volume quantification as novel biomarkers in risk stratification of patients with systemic sclerosis. Clin Radiol 76(2):162.e1-162.e8. https:\/\/doi.org\/10.1016\/j.crad.2020.09.023","journal-title":"Clin Radiol"},{"key":"8923_CR26","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1136\/heartjnl-2012-303052","volume":"99","author":"S Bull","year":"2013","unstructured":"Bull S, White SK, Piechnik SK, Flett AS, Ferreira VM, Loudon M et al (2013) Human noncontrast T1 values and correlation with histology in diffuse fibrosis. Heart 99:932\u2013937","journal-title":"Heart"},{"key":"8923_CR27","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1161\/CIRCULATIONAHA.109.930636","volume":"122","author":"AS Flett","year":"2010","unstructured":"Flett AS, Hayward MP, Ashworth MT, Hansen MS, Taylor AM, Elliott PM et al (2010) Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation 122:138\u2013144","journal-title":"Circulation"},{"key":"8923_CR28","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.jcmg.2013.01.011","volume":"6","author":"SK White","year":"2013","unstructured":"White SK, Sado DM, Fontana M, Banypersad SM, Maestrini V, Flett AS et al (2013) T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique. JACC Cardiovasc Imaging 6:955\u2013962","journal-title":"JACC Cardiovasc Imaging"},{"key":"8923_CR29","doi-asserted-by":"crossref","unstructured":"Fontana M, White SK, Banypersad SM, Sado DM, MaestriniV, Flett AS et al (2012) Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR. J Cardiovasc Magn Reson 14:88","DOI":"10.1186\/1532-429X-14-88"},{"key":"8923_CR30","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1148\/radiol.13131280","volume":"271","author":"F Thuny","year":"2014","unstructured":"Thuny F, Lovric D, Schnell F, Bergerot C, Ernande L, Cottin V et al (2014) Quantification of myocardial extracellular volume fraction with cardiac MR imaging for early detection of left ventricle involvement in systemic sclerosis. Radiology 271:373\u2013380","journal-title":"Radiology"},{"key":"8923_CR31","doi-asserted-by":"publisher","unstructured":"Mavrogeni SI, Buch M, Markousis-Mavrogenis G, Dumitru B, Pugliese NR, Gargani L (2020) The perpetual sword of Damocles: cardiac involvement in systemic sclerosis and the role of non-invasive imaging modalities in medical decision making. Eur J Rheumatol 7(Suppl 3):S203-S211.\u00a0https:\/\/doi.org\/10.5152\/eurjrheum.2020.19110\u00a0(Epub 2020 Jul 20. PMID: 32697932; PMCID: PMC7647675)","DOI":"10.5152\/eurjrheum.2020.19110"},{"key":"8923_CR32","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1136\/ard.55.7.455","volume":"55","author":"G Valentini","year":"1996","unstructured":"Valentini G, Vitale DF, Giunta A, Malone S, Gerundo G, Arnese M, Tirri E, Pelaggi N, Giacummo A, Tirri G, Condorelli M (1996) Diastolic abnormalities in systemic sclerosis: evidence for associated defective cardiac function reserve. Ann Rheum Dis 55:455\u2013460","journal-title":"Ann Rheum Dis"},{"key":"8923_CR33","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jacc.2010.02.047","volume":"56","author":"C Jellis","year":"2010","unstructured":"Jellis C, Martin J, Narula J, Marwick TH (2010) Assessment of nonischemic myocardial fibrosis. J Am Coll Cardiol 56:89\u201397","journal-title":"J Am Coll Cardiol"},{"key":"8923_CR34","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1161\/CIRCIMAGING.108.838367","volume":"2","author":"A Moreo","year":"2009","unstructured":"Moreo A, Ambrosio G, de Chiara B, Pu M, Tran T, Mauri F, Raman SV (2009) Influence of myocardial fibrosis on left ventricular diastolic function: noninvasive assessment by cardiac magnetic resonance and echo. Circ Cardiovasc Imaging 2:437\u2013443","journal-title":"Circ Cardiovasc Imaging"},{"issue":"1","key":"8923_CR35","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1093\/ehjci\/jeu167","volume":"16","author":"A Barison","year":"2015","unstructured":"Barison A, Gargani L, De Marchi D, Aquaro GD, Guiducci S, Picano E, Cerinic MM, Pingitore A (2015) Early myocardial and skeletal muscle interstitial remodelling in systemic sclerosis: insights from extracellular volume quantification using cardiovascular magnetic resonance. Eur Heart J Cardiovasc Imaging 16(1):74\u201380. https:\/\/doi.org\/10.1093\/ehjci\/jeu167","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"5","key":"8923_CR36","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1007\/s00330-019-06643-5","volume":"30","author":"F Yang","year":"2020","unstructured":"Yang F, Wang J, Li W, Xu Y, Wan K, Zeng R, Chen Y (2020) The prognostic value of late gadolinium enhancement in myocarditis and clinically suspected myocarditis: systematic review and meta-analysis. Eur Radiol 30(5):2616\u20132626. https:\/\/doi.org\/10.1007\/s00330-019-06643-5","journal-title":"Eur Radiol"},{"issue":"8","key":"8923_CR37","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1093\/rheumatology\/kez494.PMID:31764972;PMCID:PMC7382593","volume":"59","author":"S Mavrogeni","year":"2020","unstructured":"Mavrogeni S, Gargani L, Pepe A, Monti L, Markousis-Mavrogenis G, De Santis M, De Marchi D, Koutsogeorgopoulou L, Karabela G, Stavropoulos E, Katsifis G, Bratis K, Bellando-Randone S, Guiducci S, Bruni C, Moggi-Pignone A, Dimitroulas T, Kolovou G, Bournia VK, Sfikakis PP, Matucci-Cerinic M (2020) Cardiac magnetic resonance predicts ventricular arrhythmias in scleroderma: the Scleroderma Arrhythmia Clinical Utility Study (SAnCtUS). Rheumatology (Oxford) 59(8):1938\u20131948. https:\/\/doi.org\/10.1093\/rheumatology\/kez494.PMID:31764972;PMCID:PMC7382593","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"8923_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.653950","volume":"23","author":"G De Luca","year":"2021","unstructured":"De Luca G, Cavalli G, Campochiaro C, Bruni C, Tomelleri A, Dagna L, Matucci-Cerinic M (2021) Interleukin-1 and systemic sclerosis: getting to the heart of cardiac involvement. Front Immunol 23(12):653950. https:\/\/doi.org\/10.3389\/fimmu.2021.653950","journal-title":"Front Immunol"},{"issue":"9","key":"8923_CR39","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.3389\/fimmu.2018.01335","volume":"13","author":"G De Luca","year":"2018","unstructured":"De Luca G, Cavalli G, Campochiaro C, Tresoldi M, Dagna L (2018) Myocarditis: an interleukin-1-mediated disease? Front Immunol 13(9):1335. https:\/\/doi.org\/10.3389\/fimmu.2018.01335","journal-title":"Front Immunol"},{"key":"8923_CR40","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1056\/NEJMoa1415921","volume":"373","author":"S Bosello","year":"2015","unstructured":"Bosello S, De Luca G, Ferraccioli G (2015) Troponin in stable ischemic heart disease and diabetes. N Engl J Med 373:1977\u20131978. https:\/\/doi.org\/10.1056\/NEJMoa1415921","journal-title":"N Engl J Med"},{"key":"8923_CR41","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ejim.2018.10.013","volume":"60","author":"S Bosello","year":"2019","unstructured":"Bosello S, De Luca G, Berardi G et al (2019) Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: a prospective study. Eur J Intern Med 60:46\u201353. https:\/\/doi.org\/10.1016\/j.ejim.2018.10.013","journal-title":"Eur J Intern Med"},{"issue":"280","key":"8923_CR42","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ijcard.2018.11.104","volume":"1","author":"G Peretto","year":"2019","unstructured":"Peretto G, Sala S, De Luca G, Campochiaro C, Sartorelli S, Cappelletti AM et al (2019) Impact of systemic immune-mediated diseases on clinical features and prognosis of patients with biopsy-proved myocarditis. Int J Cardiol 1(280):110\u2013116. https:\/\/doi.org\/10.1016\/j.ijcard.2018.11.104","journal-title":"Int J Cardiol"},{"issue":"4","key":"8923_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153012","volume":"11","author":"G De Luca","year":"2016","unstructured":"De Luca G, Bosello SL, Gabrielli FA, Berardi G, Parisi F, Rucco M et al (2016) Prognostic role of ventricular ectopic beats in systemic sclerosis: a prospective cohort study shows ECG indexes predicting the worse outcome. PLoS ONE 11(4):e0153012. https:\/\/doi.org\/10.1371\/journal.pone.0153012","journal-title":"PLoS ONE"},{"issue":"239","key":"8923_CR44","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ijcard.2017.03.088","volume":"15","author":"G De Luca","year":"2017","unstructured":"De Luca G, Bosello SL, Canestrari G, Cavalli G, Dagna L, Ferraccioli G (2017) QTc interval prolongation in systemic sclerosis: correlations with clinical variables and arrhythmic risk. Int J Cardiol 15(239):33. https:\/\/doi.org\/10.1016\/j.ijcard.2017.03.088","journal-title":"Int J Cardiol"},{"issue":"1","key":"8923_CR45","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3109\/03009742.2016.1157626","volume":"46","author":"G De Luca","year":"2017","unstructured":"De Luca G, Bosello S, Leone AM, Gabrielli F, Pelargonio G, Inzani F et al (2017) Life-threatening arrhythmias in a scleroderma patient: the role of myocardial inflammation in arrhythmic outburst. Scand J Rheumatol 46(1):78\u201380. https:\/\/doi.org\/10.3109\/03009742.2016.1157626","journal-title":"Scand J Rheumatol"},{"key":"8923_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/03009742.2018.1493744","volume":"30","author":"G De Luca","year":"2018","unstructured":"De Luca G, Campochiaro C, Sartorelli S, Franchini S, Candela C, Peretto G et al (2018) Unexpected acute lymphocytic virus-negative myocarditis in a patient with limited cutaneous systemic sclerosis: a case report. Scand J Rheumatol 30:1\u20132. https:\/\/doi.org\/10.1080\/03009742.2018.1493744","journal-title":"Scand J Rheumatol"},{"key":"8923_CR47","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3109\/03009740903493741","volume":"39","author":"J Stack","year":"2010","unstructured":"Stack J, Mc Laughlin P, Sinnot C et al (2010) Successful control of scleroderma myocarditis using a combination of cyclophosphamide and methylprednisolone. Scand J Rheumatol 39:349\u2013350","journal-title":"Scand J Rheumatol"},{"key":"8923_CR48","doi-asserted-by":"crossref","unstructured":"De Luca G, Campochiaro C, Sartorelli S et al (2020) Efficacy and safety of mycophenolate mofetil in patients with virus-negative lymphocytic myocarditis: a prospective cohort study. J Autoimmun 106:102330","DOI":"10.1016\/j.jaut.2019.102330"},{"key":"8923_CR49","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000001194","author":"C Campochiaro","year":"2019","unstructured":"Campochiaro C, De Luca G, Tomelleri A, Sartorelli S, Peretto G, Sala S, Palmisano A, Esposito A, Cavalli G, Dagna L (2019) Tocilizumab for the treatment of myocardial inflammation shown by cardiac magnetic resonance: report of two cases and rationale for its therapeutic use. J Clin Rheumatol. https:\/\/doi.org\/10.1097\/RHU.0000000000001194","journal-title":"J Clin Rheumatol"},{"issue":"1","key":"8923_CR50","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s13244-015-0444-7","volume":"7","author":"A Esposito","year":"2016","unstructured":"Esposito A, Francone M, Faletti R et al (2016) Lights and shadows of cardiac magnetic resonance imaging in acute myocarditis. Insights Imaging 7(1):99\u2013110. https:\/\/doi.org\/10.1007\/s13244-015-0444-7","journal-title":"Insights Imaging"},{"issue":"1","key":"8923_CR51","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s00392-016-1018-5","volume":"106","author":"UK Radunski","year":"2017","unstructured":"Radunski UK, Lund GK, S\u00e4ring D, Bohnen S, Stehning C, Schnackenburg B, Avanesov M, Tahir E, Adam G, Blankenberg S, Muellerleile K (2017) T1 and T2 mapping cardiovascular magnetic resonance imaging techniques reveal unapparent myocardial injury in patients with myocarditis. Clin Res Cardiol 106(1):10\u201317. https:\/\/doi.org\/10.1007\/s00392-016-1018-5","journal-title":"Clin Res Cardiol"},{"issue":"7","key":"8923_CR52","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216070","volume":"80","author":"C Campochiaro","year":"2021","unstructured":"Campochiaro C, De Luca G, De Santis M (2021) Anti-Ku syndrome with elevated CK: association with myocardial involvement in systemic sclerosis. Ann Rheum Dis 80(7):e113. https:\/\/doi.org\/10.1136\/annrheumdis-2019-216070","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"8923_CR53","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1093\/ehjci\/jex007","volume":"18","author":"S Bohnen","year":"2017","unstructured":"Bohnen S, Radunski UK, Lund GK, Ojeda F, Looft Y, Senel M, Radziwolek L, Avanesov M, Tahir E, Stehning C, Schnackenburg B, Adam G, Blankenberg S, Muellerleile K (2017) Tissue characterization by T1 and T2 mapping cardiovascular magnetic resonance imaging to monitor myocardial inflammation in healing myocarditis. Eur Heart J Cardiovasc Imaging 18(7):744\u2013751. https:\/\/doi.org\/10.1093\/ehjci\/jex007","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"1","key":"8923_CR54","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12968-017-0389-8.Erratum.In:JCardiovascMagnReson.2018Feb7;20(1):9.PMID:28992817;PMCID:PMC5633041","volume":"19","author":"DR Messroghli","year":"2017","unstructured":"Messroghli DR, Moon JC, Ferreira VM, Grosse-Wortmann L, He T, Kellman P, Mascherbauer J, Nezafat R, Salerno M, Schelbert EB, Taylor AJ, Thompson R, Ugander M, van Heeswijk RB, Friedrich MG (2017) Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson 19(1):75. https:\/\/doi.org\/10.1186\/s12968-017-0389-8.Erratum.In:JCardiovascMagnReson.2018Feb7;20(1):9.PMID:28992817;PMCID:PMC5633041","journal-title":"J Cardiovasc Magn Reson"},{"key":"8923_CR55","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/0002-9343(79)91057-X","volume":"66","author":"J Gottdiener","year":"1979","unstructured":"Gottdiener J, Moutsopoulos H, Decker J (1979) Echocardiographic identification of cardiac abnormality in scleroderma and related disorders. Am J Med 66:391","journal-title":"Am J Med"},{"key":"8923_CR56","doi-asserted-by":"crossref","unstructured":"Khouzam RN, D\u2019Cruz IA, ArroyoM, Minderman D (2008) Systemic scleroderma with moderate to severe mitral regurgitation: unusual three-dimensional echocardiographic features. Can J Cardiol 24:152","DOI":"10.1016\/S0828-282X(08)70576-2"},{"issue":"Suppl. 1","key":"8923_CR57","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.2459\/JCM.0b013e328365aa9d","volume":"16","author":"G Ferrari","year":"2015","unstructured":"Ferrari G, Pratali S, Pucci A, Bortolotti U (2015) Aortic valve replacement in systemic sclerosis. J Cardiovasc Med (Hagerstown) 16(Suppl. 1):S60\u2013S61","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"8923_CR58","first-page":"2171","volume":"23","author":"M Penmetcha","year":"1996","unstructured":"Penmetcha M, Rosenbush SW, Harris CA (1996) Cardiac valvular disease in scleroderma and systemic lupus erythematosus\/scleroderma overlap associated with antiphospholipid antibodies. J Rheumatol 23:2171\u20132174","journal-title":"J Rheumatol"},{"issue":"11","key":"8923_CR59","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1136\/ard.62.11.1088","volume":"62","author":"D Mukerjee","year":"2003","unstructured":"Mukerjee D, St George D, Coleiro B, Knight C, Denton CP, Davar J, Black CM, Coghlan JG (2003) Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 62(11):1088\u20131093. https:\/\/doi.org\/10.1136\/ard.62.11.1088","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 5","key":"8923_CR60","doi-asserted-by":"publisher","first-page":"v42","DOI":"10.1093\/rheumatology\/ken284","volume":"47","author":"A Vonk Noordegraaf","year":"2008","unstructured":"Vonk Noordegraaf A, Naeije R (2008) Right ventricular function in scleroderma-related pulmonary hypertension. Rheumatology (Oxford) 47(Suppl 5):v42\u2013v43. https:\/\/doi.org\/10.1093\/rheumatology\/ken284","journal-title":"Rheumatology (Oxford)"},{"key":"8923_CR61","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"N Gali\u00e8","year":"2016","unstructured":"Gali\u00e8 N, Humbert M, Vachiery JL (2016) 2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 37:67\u2013119","journal-title":"Eur Heart J"},{"key":"8923_CR62","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1136\/annrheumdis-2013-203301","volume":"73","author":"JG Coghlan","year":"2014","unstructured":"Coghlan JG, Denton CP, Gruenig E, Bonderman D, Distler O, Khanna D, Muller-Ladner U, Pope JE, Vonk MC, Doelberg M, Chadha-Boreham H, Heinzl H, Rosenberg DM, McLaughlin VV, Seibold JR (2014) Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study. Ann Rheum Dis 73:1340\u20131349","journal-title":"Ann Rheum Dis"},{"issue":"21","key":"8923_CR63","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/j.jacc.2008.08.033","volume":"52","author":"R Benza","year":"2008","unstructured":"Benza R, Biederman R, Murali S, Gupta H (2008) Role of cardiac magnetic resonance imaging in the management of patients with pulmonary arterial hypertension. J Am Coll Cardiol 52(21):1683\u20131692. https:\/\/doi.org\/10.1016\/j.jacc.2008.08.033","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"8923_CR64","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1532-429X-14-11","volume":"14","author":"BH Freed","year":"2012","unstructured":"Freed BH, Gomberg-Maitland M, Chandra S, Mor-Avi V, Rich S, Archer SL, Jamison EB Jr, Lang RM, Patel AR (2012) Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension. J Cardiovasc Magn Reson 14(1):11. https:\/\/doi.org\/10.1186\/1532-429X-14-11","journal-title":"J Cardiovasc Magn Reson"},{"issue":"1","key":"8923_CR65","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1532-429X-15-86","volume":"15","author":"M Kanski","year":"2013","unstructured":"Kanski M, Arheden H, Wuttge DM, Bozovic G, Hesselstrand R, Ugander M (2013) Pulmonary blood volume indexed to lung volume is reduced in newly diagnosed systemic sclerosis compared to normals\u2013a prospective clinical cardiovascular magnetic resonance study addressing pulmonary vascular changes. J Cardiovasc Magn Reson 15(1):86. https:\/\/doi.org\/10.1186\/1532-429X-15-86","journal-title":"J Cardiovasc Magn Reson"},{"issue":"1","key":"8923_CR66","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1532-429X-14-40","volume":"14","author":"AJ Swift","year":"2012","unstructured":"Swift AJ, Rajaram S, Condliffe R, Capener D, Hurdman J, Elliot CA, Wild JM, Kiely DG (2012) Diagnostic accuracy of cardiovascular magnetic resonance imaging of right ventricular morphology and function in the assessment of suspected pulmonary hypertension results from the ASPIRE registry. J Cardiovasc Magn Reson 14(1):40. https:\/\/doi.org\/10.1186\/1532-429X-14-40","journal-title":"J Cardiovasc Magn Reson"},{"issue":"3","key":"8923_CR67","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s10554-015-0787-7","volume":"32","author":"OA Spruijt","year":"2016","unstructured":"Spruijt OA, Vissers L, Bogaard HJ, Hofman MB, Vonk-Noordegraaf A, Marcus JT (2016) Increased native T1-values at the interventricular insertion regions in precapillary pulmonary hypertension. Int J Cardiovasc Imaging 32(3):451\u2013459. https:\/\/doi.org\/10.1007\/s10554-015-0787-7","journal-title":"Int J Cardiovasc Imaging"},{"issue":"12","key":"8923_CR68","first-page":"2431","volume":"34","author":"GP Bezante","year":"2007","unstructured":"Bezante GP, Rollando D, Sessarego M, Panico N, Setti M, Filaci G, Molinari G, Balbi M, Cutolo M, Barsotti A, Indiveri F, Ghio M (2007) Cardiac magnetic resonance imaging detects subclinical right ventricular impairment in systemic sclerosis. J Rheumatol 34(12):2431\u20132437","journal-title":"J Rheumatol"},{"issue":"3","key":"8923_CR69","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1016\/j.ijcard.2013.03.164","volume":"168","author":"S Mavrogeni","year":"2013","unstructured":"Mavrogeni S, Gialafos E, Karabela G, Stavropoulos E, Sfendouraki E, Kolovou G (2013) \u201cThe silence of lambs\u201d: cardiac lesions in asymptomatic immune-mediated diseases detected by cardiovascular magnetic resonance. Int J Cardiol 168(3):2901\u20132902. https:\/\/doi.org\/10.1016\/j.ijcard.2013.03.164","journal-title":"Int J Cardiol"},{"issue":"6","key":"8923_CR70","doi-asserted-by":"publisher","first-page":"e268","DOI":"10.1016\/j.ejrad.2013.02.014","volume":"82","author":"E Di Cesare","year":"2013","unstructured":"Di Cesare E, Battisti S, Di Sibio A, Cipriani P, Giacomelli R, Liakouli V, Ruscitti P, Masciocchi C (2013) Early assessment of sub-clinical cardiac involvement in systemic sclerosis (SSc) using delayed enhancement cardiac magnetic resonance (CE-MRI). Eur J Radiol 82(6):e268\u2013e273. https:\/\/doi.org\/10.1016\/j.ejrad.2013.02.014","journal-title":"Eur J Radiol"},{"issue":"12","key":"8923_CR71","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s11547-014-0419-7","volume":"119","author":"N Schicchi","year":"2014","unstructured":"Schicchi N, Valeri G, Moroncini G, Agliata G, Salvolini L, Gabrielli A, Giovagnoni A (2014) Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance. Radiol Med 119(12):885\u2013894. https:\/\/doi.org\/10.1007\/s11547-014-0419-7","journal-title":"Radiol Med"},{"key":"8923_CR72","doi-asserted-by":"publisher","unstructured":"Sano M, Satoh H, Suwa K, Nobuhara M, Saitoh T, Saotome M, Urushida T, Katoh H, Shimoyama K, Suzuki D, Ogawa N, Takehara Y, Sakahara H, Hayashi H (2015) Characteristics and clinical relevance of late gadolinium enhancement in cardiac magnetic resonance in patients with systemic sclerosis. Heart Vessels 30(6):779\u201388.\u00a0https:\/\/doi.org\/10.1007\/s00380-014-0539-y\u00a0(Epub 2014 Jul 5. PMID: 24996373; PMCID: PMC4648959)","DOI":"10.1007\/s00380-014-0539-y"},{"key":"8923_CR73","doi-asserted-by":"publisher","unstructured":"Mavrogeni SI, Bratis K, Karabela G, Spiliotis G, Wijk Kv, Hautemann D, Reiber JH, Koutsogeorgopoulou L, Markousis-Mavrogenis G, Kolovou G, Stavropoulos E (2015) Cardiovascular magnetic resonance imaging clarifies cardiac pathophysiology in early, asymptomatic diffuse systemic sclerosis. Inflamm Allergy Drug Targets 14(1):29\u201336.\u00a0https:\/\/doi.org\/10.2174\/1871528114666150916112551","DOI":"10.2174\/1871528114666150916112551"},{"key":"8923_CR74","doi-asserted-by":"crossref","unstructured":"Smith V, Scire CA, Talarico R et al (2018) Systemic sclerosis: state of the art on clinical practice guidelines. RMD Open 4(Suppl 1):e000782","DOI":"10.1136\/rmdopen-2018-000788"},{"key":"8923_CR75","doi-asserted-by":"crossref","unstructured":"Allanore Y, Meune C, Vonk MC et al (2010) Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis. Ann Rheum Dis 69(1): 218e21","DOI":"10.1136\/ard.2008.103382"},{"key":"8923_CR76","doi-asserted-by":"publisher","unstructured":"Valentini G, Huscher D, Riccardi A et al (2019) Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort study. Ann Rheum Dis 78(11):1576e82. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215486","DOI":"10.1136\/annrheumdis-2019-215486"},{"key":"8923_CR77","doi-asserted-by":"crossref","unstructured":"Pingitore A, Guiducci S, Conforti ML et al (2013) Early detection of myocardial and pulmonary oedema with MRI in an asymptomatic systemic sclerosis patient: successful recovery with pulse steroid. Rheumatology 52(10):1920e1","DOI":"10.1093\/rheumatology\/ket002"},{"issue":"1","key":"8923_CR78","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12872-017-0619-x","volume":"17","author":"S Mavrogeni","year":"2017","unstructured":"Mavrogeni S, Koutsogeorgopoulou L, Karabela G et al (2017) Silent myocarditis in systemic sclerosis detected by cardiovascular magnetic resonance using Lake Louise criteria. BMC Cardiovasc Disord 17(1):187","journal-title":"BMC Cardiovasc Disord"},{"issue":"2020","key":"8923_CR79","doi-asserted-by":"publisher","first-page":"8884442","DOI":"10.1155\/2020\/8884442","volume":"19","author":"B Pussadhamma","year":"2020","unstructured":"Pussadhamma B, Tipparot T, Chaosuwannakit N, Mahakkanukrauh A, Suwannaroj S, Nanagara R, Foocharoen C (2020) Clinical outcomes of myocarditis after moderate-dose steroid therapy in systemic sclerosis: a pilot study. Int J Rheumatol 19(2020):8884442. https:\/\/doi.org\/10.1155\/2020\/8884442","journal-title":"Int J Rheumatol"},{"issue":"4","key":"8923_CR80","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.1097\/RHU.0000000000000897","volume":"27","author":"C Campochiaro","year":"2021","unstructured":"Campochiaro C, De Luca G, Sartorelli S, Tomelleri A, Esposito A, Candela C, Cavalli G, Dagna L (2021) Efficacy and safety of methotrexate for the treatment of autoimmune virus-negative myocarditis: a case series. J Clin Rheumatol 27(4):e143\u2013e146. https:\/\/doi.org\/10.1097\/RHU.0000000000000897","journal-title":"J Clin Rheumatol"},{"issue":"11","key":"8923_CR81","doi-asserted-by":"publisher","first-page":"819","DOI":"10.7326\/L18-0315","volume":"169","author":"G De Luca","year":"2018","unstructured":"De Luca G, Campochiaro C, Dinarello CA, Dagna L, Cavalli G (2018) Treatment of dilated cardiomyopathy with interleukin-1 inhibition. Ann Intern Med 169(11):819\u2013820. https:\/\/doi.org\/10.7326\/L18-0315","journal-title":"Ann Intern Med"},{"issue":"21","key":"8923_CR82","doi-asserted-by":"publisher","first-page":"00266","DOI":"10.1016\/j.ejim.2021.07.016","volume":"S0953\u20136205","author":"C Campochiaro","year":"2021","unstructured":"Campochiaro C, Farina N, Tomelleri A, Ferrara R, Lazzari C, De Luca G, Alessandra B, Signorelli D, Palmisano A, Vignale D, Peretto G, Sala S, Esposito A, Garassino M, Gregorc V, Dagna L (2021) Tocilizumab for the treatment of immune-related adverse events: a systematic literature review and a multicentre case series. Eur J Intern Med S0953\u20136205(21):00266\u201300271. https:\/\/doi.org\/10.1016\/j.ejim.2021.07.016","journal-title":"Eur J Intern Med"},{"key":"8923_CR83","doi-asserted-by":"crossref","unstructured":"Al-mashaleh M, Bak H, Moore J et al (2006) Resolution of sclerodermatous myocarditis after autologous stem cell transplantation. Ann Rheum Dis 65(9):1247e8","DOI":"10.1136\/ard.2005.048405"},{"key":"8923_CR84","doi-asserted-by":"crossref","unstructured":"Henes JC, Koetter I, Horger M et al (2014) Autologous stem cell transplantation with thiotepa-based conditioning in patients with systemic sclerosis and cardiac manifestations. Rheumatology 53(5):919e22","DOI":"10.1093\/rheumatology\/ket464"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-022-08923-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-022-08923-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-022-08923-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T08:15:23Z","timestamp":1683706523000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-022-08923-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,24]]},"references-count":84,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["8923"],"URL":"https:\/\/doi.org\/10.1007\/s12016-022-08923-3","relation":{},"ISSN":["1559-0267"],"issn-type":[{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,24]]},"assertion":[{"value":"6 January 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}